Skip to content

What are the symptoms of the last syndrome? A Guide to Local Anesthetic Systemic Toxicity (LAST)

3 min read

Local Anesthetic Systemic Toxicity (LAST) is a rare but life-threatening complication of local anesthetic administration, with an incidence estimated to be as low as 0.03% per peripheral nerve block. Knowing what are the symptoms of the last syndrome is crucial for rapid recognition and intervention, which is key to a positive outcome.

Quick Summary

Local anesthetic systemic toxicity (LAST) affects the central nervous system and cardiovascular system, presenting with signs from mild agitation and perioral numbness to severe seizures, arrhythmias, and cardiac arrest. Presentations can be typical, with initial neurological signs, or atypical, with isolated cardiovascular issues.

Key Points

  • LAST Affects CNS and CVS: Local Anesthetic Systemic Toxicity (LAST) can cause symptoms in both the central nervous system (CNS) and the cardiovascular system (CVS).

  • Biphasic CNS Symptoms: The neurological effects of LAST often progress from early excitation (e.g., agitation, tinnitus, perioral numbness) to later depression (e.g., seizures, coma, respiratory arrest).

  • Diverse CVS Effects: Cardiovascular symptoms can include heart rate changes (bradycardia, tachycardia), hypotension, arrhythmias, and cardiac arrest.

  • Atypical Presentations Are Common: Around 40% of LAST cases present atypically, meaning they may lack preceding CNS symptoms or have a delayed onset, sometimes with isolated CVS signs.

  • Lipid Emulsion Is Key: The emergency treatment for severe LAST involves supportive care and the prompt administration of a 20% lipid emulsion, which helps reverse toxicity.

  • Prevention is Paramount: Using the lowest effective dose, aspirating before injection, and utilizing ultrasound guidance can significantly reduce the risk of LAST.

In This Article

Understanding Local Anesthetic Systemic Toxicity (LAST)

Local Anesthetic Systemic Toxicity (LAST) is a rare but critical adverse drug reaction caused by high levels of a local anesthetic in the bloodstream. This can occur due to accidental injection into a blood vessel, a high dose, or rapid absorption. Local anesthetics block voltage-gated sodium channels in nerve cells to prevent pain, but toxic concentrations can affect these channels in the central nervous system (CNS) and heart, leading to dysfunction. The clinical picture can be complex, and while prompt treatment with therapies like lipid emulsion is highly effective, delayed recognition can have severe consequences.

The Manifestations: What are the symptoms of the last syndrome?

The signs and symptoms of LAST primarily affect the central nervous system and the cardiovascular system, with presentations ranging from subtle to life-threatening. The clinical course is variable and influenced by the specific local anesthetic and patient factors.

Central Nervous System (CNS) Symptoms

Typically, CNS symptoms occur first, starting with excitation and progressing to depression.

Initial excitatory signs:

  • Metallic taste
  • Perioral paresthesia
  • Tinnitus
  • Dizziness
  • Visual disturbances
  • Agitation/Confusion
  • Slurred speech
  • Muscle twitching/tremors

Late depressive signs:

  • Seizures
  • Lethargy/Drowsiness
  • Loss of consciousness/Coma
  • Respiratory depression/arrest

Cardiovascular System (CVS) Symptoms

Cardiovascular effects are dangerous and can occur after CNS signs or, in atypical cases, without preceding neurological symptoms.

Cardiovascular signs:

  • Heart rate changes (bradycardia, tachycardia)
  • Hypotension
  • Arrhythmias
  • Decreased contractility/conduction abnormalities
  • Cardiac arrest

Atypical Presentations

Atypical presentations occur in approximately 40% of cases, without the classic progression. Patients may present only with cardiovascular symptoms, and onset can be delayed by over an hour. Bupivacaine is more likely to cause significant isolated cardiac issues.

Factors Influencing LAST Severity

Factors like the local anesthetic used, dose, and patient characteristics influence risk and severity. High-potency agents like bupivacaine pose a higher cardiac toxicity risk. Patient factors include age extremes, pregnancy, and pre-existing heart, liver, or kidney disease.

Comparison of Mild vs. Severe LAST Symptoms

Severity guides medical response:

Severity Central Nervous System (CNS) Symptoms Cardiovascular System (CVS) Symptoms
Mild - Metallic taste
- Numbness around mouth
- Tinnitus
- Dizziness
- Agitation
- Confusion
- Mild hypertension
- Mild tachycardia
Severe - Seizures
- Slurred speech
- Visual disturbances
- Loss of consciousness
- Respiratory depression
- Coma
- Hypotension
- Bradycardia
- Arrhythmias
- Conduction blocks
- Cardiac arrest (asystole, VF)

Emergency Management of LAST

Rapid response is essential. Key steps involve discontinuing the anesthetic, supportive care, and targeted treatment, including 20% lipid emulsion.

Immediate Actions include:

  • Stop Injection: Immediately cease anesthetic administration.
  • Call for Help: Activate emergency protocols.
  • Airway Management: Ensure a patent airway, provide oxygen, and assist ventilation.
  • Seizure Control: Use benzodiazepines (Propofol cautiously due to hypotension risk).
  • Lipid Emulsion Therapy: Infuse 20% lipid emulsion (bolus then infusion).
  • ACLS: Implement ACLS for cardiac arrest, with modifications like using small epinephrine doses.

Conclusion: Vigilance and Preparedness

LAST is rare but severe. Prevention (lowest effective dose, intermittent injection, ultrasound guidance) is vital. Due to atypical presentations, suspect LAST with unexpected neurological or cardiovascular changes. Prompt recognition of what are the symptoms of the last syndrome? and immediate treatment are critical. More information is available from the Anesthesia Patient Safety Foundation.

You can find more information here.

Frequently Asked Questions

Seizures are the most common severe initial sign of Local Anesthetic Systemic Toxicity (LAST), although mild symptoms like perioral numbness and metallic taste may appear first.

Yes, LAST can develop from topical application of local anesthetics, although it is less common than with injections. It can also result from application to the mucosa in the mouth, esophagus, and trachea.

Emergency treatment for LAST includes immediately stopping the anesthetic, managing the patient's airway and breathing, controlling seizures with benzodiazepines, and administering an intravenous infusion of a 20% lipid emulsion.

Bupivacaine is one of the local anesthetics associated with a higher risk of LAST, especially for causing significant cardiac toxicity, due to its low safety margin.

While LAST symptoms typically appear within minutes of a local anesthetic injection, atypical and delayed presentations can occur 30 minutes or even longer after the injection.

Yes, patient risk factors for LAST include extremes of age (infants and elderly), pregnancy, low muscle mass, metabolic acidosis, and pre-existing heart, liver, or kidney disease.

Lipid emulsion therapy is thought to work by creating a 'lipid sink' in the blood that absorbs the lipophilic local anesthetic, reducing the concentration of the drug available to affect the heart and brain.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.